Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion

F. Zhang, C. Li, R. Wang, D. Han, Quanguang Zhang, C. Zhou, H. M. Yu, G. Y. Zhang

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Cerebral ischemia can induce both the increase of excitation and the decrease of inhibition, which leads to neuronal excitotoxicity. Since glutamatergic and GABAergic transmissions work by each counterbalancing the function of the other, enhancing GABAergic activity should balance excessive glutamatergic excitation. But the potential mechanisms underlying these effects are obscure. Here, we used two GABA agonists, muscimol and baclofen, and performed immunoblotting, immunoprecipitation and histology analysis to evaluate the neuroprotective effects by stimulating GABA receptors in rat four-vessel occlusion (4-VO) ischemic model, and to investigate the potential mechanism. Our results indicate that whether in global cerebral ischemia in vivo, or in oxygen glucose deprivation (OGD) in vitro, coapplication of muscimol with baclofen can protect neurons from neuronal death through down-regulating the function of N-methyl-d-aspartic acid (NMDA) receptors via attenuating the tyrosine phosphorylation of NR2A subunit. We further elucidate that the phosphorylation level of Src kinase and the interaction among Src, post-synaptic density protein 95 and NR2A were also suppressed by coapplication of muscimol with baclofen. Both MK-801, a specific antagonist of NMDA receptors, and chelerythrine, an inhibitor of protein kinase C (PKC), could down-regulate the phosphorylation of NR2A via inhibiting the activation of Src and PKC respectively. These results suggest that the modified pattern of dynamic balance between excitation and inhibition by coactivation of the GABA receptors in cerebral ischemia can attenuate the excitatory NMDAR via inhibiting a novel postsynaptic NMDAR/Src-mediated signal amplification, the 'NMDAR-Ca 2+ → PKC → Src → NMDAR-Ca 2+ ' cycle.

Original languageEnglish (US)
Pages (from-to)938-949
Number of pages12
JournalNeuroscience
Volume150
Issue number4
DOIs
StatePublished - Dec 19 2007
Externally publishedYes

Fingerprint

Muscimol
Baclofen
GABA Receptors
Brain Ischemia
Protein Kinase C
Reperfusion
Tyrosine
src-Family Kinases
Phosphorylation
Apoptosis
GABA Agonists
Post-Synaptic Density
Dizocilpine Maleate
Neuroprotective Agents
Immunoprecipitation
Immunoblotting
Histology
Down-Regulation
Oxygen
Neurons

Keywords

  • GABA receptor
  • NMDA receptor
  • Src
  • baclofen
  • cerebral ischemia
  • muscimol

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion. / Zhang, F.; Li, C.; Wang, R.; Han, D.; Zhang, Quanguang; Zhou, C.; Yu, H. M.; Zhang, G. Y.

In: Neuroscience, Vol. 150, No. 4, 19.12.2007, p. 938-949.

Research output: Contribution to journalArticle

@article{577635d5b36947aca1af71bed09086b9,
title = "Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion",
abstract = "Cerebral ischemia can induce both the increase of excitation and the decrease of inhibition, which leads to neuronal excitotoxicity. Since glutamatergic and GABAergic transmissions work by each counterbalancing the function of the other, enhancing GABAergic activity should balance excessive glutamatergic excitation. But the potential mechanisms underlying these effects are obscure. Here, we used two GABA agonists, muscimol and baclofen, and performed immunoblotting, immunoprecipitation and histology analysis to evaluate the neuroprotective effects by stimulating GABA receptors in rat four-vessel occlusion (4-VO) ischemic model, and to investigate the potential mechanism. Our results indicate that whether in global cerebral ischemia in vivo, or in oxygen glucose deprivation (OGD) in vitro, coapplication of muscimol with baclofen can protect neurons from neuronal death through down-regulating the function of N-methyl-d-aspartic acid (NMDA) receptors via attenuating the tyrosine phosphorylation of NR2A subunit. We further elucidate that the phosphorylation level of Src kinase and the interaction among Src, post-synaptic density protein 95 and NR2A were also suppressed by coapplication of muscimol with baclofen. Both MK-801, a specific antagonist of NMDA receptors, and chelerythrine, an inhibitor of protein kinase C (PKC), could down-regulate the phosphorylation of NR2A via inhibiting the activation of Src and PKC respectively. These results suggest that the modified pattern of dynamic balance between excitation and inhibition by coactivation of the GABA receptors in cerebral ischemia can attenuate the excitatory NMDAR via inhibiting a novel postsynaptic NMDAR/Src-mediated signal amplification, the 'NMDAR-Ca 2+ → PKC → Src → NMDAR-Ca 2+ ' cycle.",
keywords = "GABA receptor, NMDA receptor, Src, baclofen, cerebral ischemia, muscimol",
author = "F. Zhang and C. Li and R. Wang and D. Han and Quanguang Zhang and C. Zhou and Yu, {H. M.} and Zhang, {G. Y.}",
year = "2007",
month = "12",
day = "19",
doi = "10.1016/j.neuroscience.2007.09.070",
language = "English (US)",
volume = "150",
pages = "938--949",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion

AU - Zhang, F.

AU - Li, C.

AU - Wang, R.

AU - Han, D.

AU - Zhang, Quanguang

AU - Zhou, C.

AU - Yu, H. M.

AU - Zhang, G. Y.

PY - 2007/12/19

Y1 - 2007/12/19

N2 - Cerebral ischemia can induce both the increase of excitation and the decrease of inhibition, which leads to neuronal excitotoxicity. Since glutamatergic and GABAergic transmissions work by each counterbalancing the function of the other, enhancing GABAergic activity should balance excessive glutamatergic excitation. But the potential mechanisms underlying these effects are obscure. Here, we used two GABA agonists, muscimol and baclofen, and performed immunoblotting, immunoprecipitation and histology analysis to evaluate the neuroprotective effects by stimulating GABA receptors in rat four-vessel occlusion (4-VO) ischemic model, and to investigate the potential mechanism. Our results indicate that whether in global cerebral ischemia in vivo, or in oxygen glucose deprivation (OGD) in vitro, coapplication of muscimol with baclofen can protect neurons from neuronal death through down-regulating the function of N-methyl-d-aspartic acid (NMDA) receptors via attenuating the tyrosine phosphorylation of NR2A subunit. We further elucidate that the phosphorylation level of Src kinase and the interaction among Src, post-synaptic density protein 95 and NR2A were also suppressed by coapplication of muscimol with baclofen. Both MK-801, a specific antagonist of NMDA receptors, and chelerythrine, an inhibitor of protein kinase C (PKC), could down-regulate the phosphorylation of NR2A via inhibiting the activation of Src and PKC respectively. These results suggest that the modified pattern of dynamic balance between excitation and inhibition by coactivation of the GABA receptors in cerebral ischemia can attenuate the excitatory NMDAR via inhibiting a novel postsynaptic NMDAR/Src-mediated signal amplification, the 'NMDAR-Ca 2+ → PKC → Src → NMDAR-Ca 2+ ' cycle.

AB - Cerebral ischemia can induce both the increase of excitation and the decrease of inhibition, which leads to neuronal excitotoxicity. Since glutamatergic and GABAergic transmissions work by each counterbalancing the function of the other, enhancing GABAergic activity should balance excessive glutamatergic excitation. But the potential mechanisms underlying these effects are obscure. Here, we used two GABA agonists, muscimol and baclofen, and performed immunoblotting, immunoprecipitation and histology analysis to evaluate the neuroprotective effects by stimulating GABA receptors in rat four-vessel occlusion (4-VO) ischemic model, and to investigate the potential mechanism. Our results indicate that whether in global cerebral ischemia in vivo, or in oxygen glucose deprivation (OGD) in vitro, coapplication of muscimol with baclofen can protect neurons from neuronal death through down-regulating the function of N-methyl-d-aspartic acid (NMDA) receptors via attenuating the tyrosine phosphorylation of NR2A subunit. We further elucidate that the phosphorylation level of Src kinase and the interaction among Src, post-synaptic density protein 95 and NR2A were also suppressed by coapplication of muscimol with baclofen. Both MK-801, a specific antagonist of NMDA receptors, and chelerythrine, an inhibitor of protein kinase C (PKC), could down-regulate the phosphorylation of NR2A via inhibiting the activation of Src and PKC respectively. These results suggest that the modified pattern of dynamic balance between excitation and inhibition by coactivation of the GABA receptors in cerebral ischemia can attenuate the excitatory NMDAR via inhibiting a novel postsynaptic NMDAR/Src-mediated signal amplification, the 'NMDAR-Ca 2+ → PKC → Src → NMDAR-Ca 2+ ' cycle.

KW - GABA receptor

KW - NMDA receptor

KW - Src

KW - baclofen

KW - cerebral ischemia

KW - muscimol

UR - http://www.scopus.com/inward/record.url?scp=36849040517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849040517&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2007.09.070

DO - 10.1016/j.neuroscience.2007.09.070

M3 - Article

VL - 150

SP - 938

EP - 949

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 4

ER -